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Although single photon emission computed tomog-
hy (SPECT) has been the cornerstone of noninvasive
ssment of coronary artery disease (CAD) and myo-
ial perfusion imaging (MPI) for many years, MPI
increasingly also involves positron emission tomog-
hy (PET). In many centers equipped with PET facil-
s, it provides a well-established technique that is
tinely used for the noninvasive imaging and quanti-
tion of myocardial perfusion and metabolism.
As PET has inherently implemented attenuation
rection, the accuracy of PET is expected to be
erior to that of SPECT. The recent introduction of
d SPECT, however, has further increased the value
PECT MPI.1 In fact, end-diastolic and end-systolic
ventricular (LV) volume and ejection fraction (EF)
important predictors of prognosis and death in
ents with cardiac disease, particularly after myocar-
infarction but also in nonischemic cardiac disease.
thermore, parameters of regional and global LV
ction are used to evaluate the efficacy of revascular-
ion in patients with CAD and chronic but reversible
dysfunction. Assessment of functional LV parame-
provides additional information, which substantially
eases the clinical impact of MPI. As no additional
iation dose needs to be applied to get this information,
hould become the clinical standard to assess function
use of electrocardiographic triggering. The old and
valid rule that radiation dose should be kept as low
reasonably achievable (ALARA) should now be
pleted by the statement on clinical information—to
ain as much as reasonably achievable (AMARA).
ilar to the development in gated SPECT, which has
the Cardiovascular Center, Nuclear Cardiology, University Hos-
ital Zurich, Zurich, Switzerland.
rint requests: Philipp A. Kaufmann, MD, Swiss National Science
oundation, Nuclear Medicine and Cardiology, University Hospital
urich, Zurich, Switzerland; pak@usz.ch.
cl Cardiol 2005;12:620-1.
-3581/$30.00
yright © 2005 by the American Society of Nuclear Cardiology.
10.1016/j.nuclcard.2005.08.004ught a large number of validation studies for each
ntification method, this has now to be repeated by the
community. Consequently, different studies have
dated the measurement of LV volumes by electrocar-
graphy-gated PET by use of different myocardial
ers such as fluorine 18 fluorodeoxyglucose2-4 or
ogen 13 ammonia.5,6 For the blood pool tracer oxy-
15–labeled carbon dioxide (CO), only limited data
small pilot studies exist, in which the protocol was
cifically chosen to measure LV volumes by gating.7-9
In this issue of the Journal of Nuclear Cardiology,
man et al10 provide evidence that LV volumes and
can be reliably measured noninvasively by means of
d PET with the use of myocardial blood pool images
tinely acquired for use in perfusion quantification.
s contributes to the above-mentioned aim to obtain as
ch information as reasonably achievable with any
lication of any radiotracer. The authors did so with
0 MBq O-15–labeled CO, resulting in an effective
e equivalent of as low as around 0.3 mSv. This
ainly meets the criterion of ALARA, as it is lower by
ut one order as compared with previous reports.7,9
asurements were performed on a PET scanner and
pared with the gold standard, magnetic resonance
ging.
Overall, despite a substantially shortened acquisition
e and lower dose, correlation was very good between
and magnetic resonance imaging for end-systolic (r
.90) and end-diastolic LV volumes (r  0.096) with
onable limits of agreement, although correlation was
htly inferior for LV EF (r  0.86). Similar to
vious reports,7 LV EF tended to be underestimated.
fact that EF was not measured on the same day by
two different techniques is probably not the main
on for these differences. It is much more plausible
, inherently, two different techniques may not mea-
exactly the same volume, for example, because of
culties in identifying the basal (mitral valve) plane. It
therefore, very important to know the normal values
each single technique with its specific equipment and
ope, and the present study is helpful in establishing
knowledge for the use of O-15–labeled CO PET
ns. At present, a major drawback is that each institu-
is using its own software, and therefore results
can
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dardization of gated SPECT measurement provided the
e to its overwhelming success. Similarly, standardiza-
of gated PET data acquisition will advance acceptance
importance of this precious technique.
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